This may be because starting doses of erythropoietin are usually similar when patients initiate CHD (as seen in Figure 2b) given the low hemoglobin levels at the initiation of hemodialysis and the ease of administration of standard doses in busy dialysis units. The gene discussed is EPO; the disease is coronary artery disorder.